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model for the biotechnologist. Several variations on thisDeath, Taxes,
theme are under development in various labs.and the Genetic Code? One strategy is to create orthologous codon/tRNA/
amino acid/ aminoacyl-tRNA synthetase (RS) combina-
tions that operate in vivo. Technically, this is a challeng-
ing approach since not only does a codon and corre-
The genetic code is an enduring feature of biology: sponding RNA have to be reassigned from the normal
only rare circumstances result in changes to transla- genetic coding functions, but the tRNA must also be
tion of the code, at least in nature. Researchers are efficiently acylated with the novel amino acid. This re-
devising methods to engineer ribosome-synthesized quires a specifically engineered RS, and, as if that were
polypeptides containing novel and potentially useful not enough, the cell must be able to tolerate the incorpo-
amino acids. ration of the new amino acid into some fraction of its
proteins. A potential advantage to an in vivo system,
however, is relatively low cost, because specific compo-Ribosomal protein synthesis is a vital biological function
nents of the translational apparatus do not need to bethat has been exploited as a valuable tool for research
purified for use in an in vitro translational system. Severaland for the production of medically and economically
groups have begun engineering RS enzymes to accom-important proteins. Translation of the typical gene re-
modate novel amino acids [5–7]. A preview article byquires that the ribosome discriminate between a large
Tamara Hendrickson published in last month’s issue ofnumber of similar aminoacyl-tRNA substrates with re-
Chemistry & Biology [8] discussed the Schultz group’smarkable speed and processivity. However, while offer-
recent progress toward the development of in vivo sys-ing tremendous utility, proteins are normally limited to
tems [e.g., 9, 10].a standard set of 20 amino acids that encompass a
Another approach is to chemically attach unnaturalnarrow range of biochemical properties. The ability to
amino acids to tRNAs in vitro. This avoids the require-artificially expand the variety of amino acids incorpo-
ment of engineering a specific RS, which may also meanrated into growing peptide chains would be one way to
that a wider variety of amino acids may be used. Twoincrease the experimental and medical utility of proteins.
recently published papers use variations of this methodFor example, residues that serve as fluorescent tags or
to generate significant advancements in this field. Ste-confer novel catalytic activities could provide break-
phen Blacklow, Virginia Cornish, and collaborators [11]through advances in protein technology. However, a
used purified components to construct an in vitro sys-
major barrier to expanding the coding repertoire is the
tem for protein synthesis. Specific messages and corre-
sheer complexity of the protein synthetic process.
sponding tRNAs are synthesized, and the tRNAs are
Changing the genetic code requires that a codon is acylated with unnatural amino acids. These are then
reassigned to a corresponding tRNA and that the tRNA added to ribosomes and accessory factors to direct
be acylated with a novel amino acid. Despite technical synthesis of the novel peptide, directed entirely by the
barriers to such alterations, recent progress by several engineered code. Thus far, they have achieved incorpo-
groups lends hope that we may soon be able to engineer ration of four novel amino acids, all with yields in the
proteins with novel and useful amino acids. tens of percent. This is remarkable considering that the
The restrictive and defined chemistries of the canoni- tRNA substrates lacked nucleoside modifications, which
cal 20 amino acids’ side chains have led nature to exten- are important for translational function [12]. Only short
sively supplement enzymes with metallic and organic peptides were constructed, and this current system
cofactors, most of which perform critical catalytic func- would not be economically competitive with chemical
tions that amino acid side chains alone simply cannot synthesis of defined peptides. It could be useful, how-
do. Nature has also dealt with the limited range of func- ever, for the synthesis of random libraries of peptides
tion by post-translational modification of amino acids. that contain unnatural amino acids. Moreover, this work
For example, the hydroxylation of proline and lysine is is an intriguing proof of principle that may be developed
critical to the functions of many structural proteins such for the production of longer polypeptides.
as collagen [1]. More exotically, certain redox enzymes The in vitro synthesis of longer polypeptides faces
contain the nonstandard amino acid selenocysteine in- several hurdles. One obstacle is increased efficiency.
corporated at UGA codons [2]. This is achieved by an Unless yields can be increased, this system may be
elaborate translational mechanism requiring a special limited to either short peptides or to longer peptides
tRNA and elongation factors as well as special message that contain one of a few unnatural amino acids. The
signals that recode UGA from stop to selenocysteine latter would still be extremely valuable because many
[3]. A similar mechanism is in place to incorporate pyrro- applications will only require a single novel amino acid.
lysine into proteins in methanogens [4]. The selenocys- Increased efficiency may also be achieved by optimizing
teine system can be considered parallel or orthogonal tRNA sequence specificity and possibly specificity for
the tRNA sequence to the amino acid [13]. Another tech-to the standard decoding system and can serve as a
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nical complication that will need to be addressed for agent electroporation may greatly facilitate one of the
longer proteins is that all of the required aminoacyl- most promising uses of the unnatural amino acid tech-
tRNAs must be included in the translational mix. Most nology: the characterization of protein function in living
simply, this could be achieved by adding cellular frac- cells.
tions containing the various translational components. I thank Dr. Rebecca Alexander for comments on a
In this case, however, the natural aminoacyl-tRNA for draft of this preview.
the reassigned codon would have to be prevented from
acting, possibly with the use of a specific RS inhibitor.
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tion of novel agents that promote degradation of theScreening for Inducers
kinases Her2 and EGFR.of Kinase Degradation
Her2 is a transmembrane receptor tyrosine kinase that
heterodimerizes with other members of the Her family
(e.g., epidermal growth factor receptor (EGFR)/Her1,Targeted small molecule-induced protein degradation
is a promising approach to inhibit signaling within ki- Her3, and Her4) and promotes the transduction of prolif-
erative and survival signals [1]. Her2 is overexpressednase cascades. In this issue, researchers describe a
simple assay for the rapid, high-throughput identifica- in a significant proportion of adenocarcinomas, and clin-
